HIV-assoziierte Tumoren

Zusammenfassung

Weltweit wird die Zahl HIV-infizierter Personen auf 17 Mio. geschätzt. 1,2 Mio. Fälle von Aids wurden durch die WHO registriert. Es wird geschätzt, dass bis zu 40% der HIV-infizierten Patienten schließlich in ihrem Krankheitsverlauf eine bösartige Krankheit erwerben. Non-Hodgkin-Lymphom (NHL), Kaposi-Sarkom und invasiver Krebs der Cervix uteri sind bei HIV-Infizierten häufiger als in der übrigen Bevölkerung und gelten als Aids-definierende Erkrankungen. Verschiedene Publikationen machen es wahrscheinlich, dass auch andere bösartige Erkrankungen bei HIV-Infizierten häufiger sind. Hierzu gehören Plattenepithelkarzinome im HNO-Bereich, maligne Erkrankungen der Analregion, Plasmozytom, Melanom, Bronchialkarzinom, Basaliom, Hodenkarzinom.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anagnostopoulos J (1997) Pathology of HIV-associated lymphomas. 10th Symp on Molecular Biology of Hematopoiesis. Juli 2–6, 1997, Hamburg, GermanyGoogle Scholar
  2. Benkerrou M, Jais JP, Leblon V (1998) Anti-B-Cell monoclonal antibody treatment of severe posttransplant Blymphoproliferative disorder: Prognostic factors and longterm outcome. Blood 92: 3137–3147Google Scholar
  3. Beral V, Peterman T, Berkelman R et al. (1991) AIDS-associated non-Hodgkin-lymphoma. Lancet 337: 805–809PubMedCrossRefGoogle Scholar
  4. Bernardi D, Salvioni R, Vaccher E et al. (1995) Testicular germ cell tumors and human immunodeficiency virus infection: A report of 26 cases. J Clin Oncol 13: 2705–2711PubMedGoogle Scholar
  5. Chamberlain MC (1994) Gliomas in patients with acquired immune deficiency syndrome. Cancer 74: 1912PubMedCrossRefGoogle Scholar
  6. Delecluse HJ, Anagnostopoulos J, Dallenbach F (1997) Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection. Blood 89: 1413–1420Google Scholar
  7. Fraire AE, Awe RJ (1992) Lung cancer in association with human immunodeficiency virus infection. Cancer 70: 432–436PubMedCrossRefGoogle Scholar
  8. Friedman SL, Wright TL, Alman DR (1985) Gastrointestinal Karposi’s sarcoma in patients with acquired immuno-deficiency syndrome: Endoscopic and autopsy findings. Gastroenterology 89: 102–108Google Scholar
  9. Gill PS, Wernz J, Scadden DT (1996) Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, vincristine in AIDS-related Kaposi’s sarcoma. J Clin Oncol 8: 2353–2364Google Scholar
  10. Goedert JJ, Coté TR, Virgo P et al. (1998) Spectrum of AIDS-associated malignant disorders. Lancet 351: 1833–1839PubMedCrossRefGoogle Scholar
  11. Harris NL, Jaffe ES, Stein H (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84: 1361–1392Google Scholar
  12. Heise W, Aarstéh K, Mostertz P et al. (1997) Malignant gastrointestinal lymphomas in patients with AIDS. Digestion 58: 218–224PubMedCrossRefGoogle Scholar
  13. Holland J, Swift P (1994) Tolerance of patients with HIV and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology 193: 251–254PubMedGoogle Scholar
  14. Huhn D (1988) Gastrointestinale Lymphome beim erworbenen Immunmangelsyndrom. Verdauungskrankheiten 7: 4852Google Scholar
  15. Huhn D (1994) HIV-assoziierte Non-Hodgkin-Lymphome. Internist 35: 906–911PubMedGoogle Scholar
  16. Kaplan LD, Straus DJ, Testa MA et al. (1997) Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin’s lymphoma associated with human immunodeficiency virus infection. N Engl J Med 336: 1641–1648PubMedCrossRefGoogle Scholar
  17. Krown SE, Metroka C, Wernz JC (1989) Kaposi’s sarcoma in the acquired immunodeficiency syndrome: A proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 7: 1201–1207Google Scholar
  18. Lowy AM, Bark PS (1994) Laparotomy in patients infected with human immunodeficiency virus. Indications and outcome. Br J Surg 81: 942–945Google Scholar
  19. Moore PS, Yuan Chang (1995) Detection of herpesvirus-like DNA sequences in Kaposi’s sarcoma in patients with and those without HIV infection. N Engl J Med 332: 1181–1185PubMedCrossRefGoogle Scholar
  20. Northfeldt D (1996) Anal neoplasia in persons with HIV-infection. AIDS Clinical Care 8: 63–66Google Scholar
  21. Oertel J, Oertel B, Lobeck H et al. (1990) Immunocytochemical analysis of lymph node aspirates in patients with human immunodeficiency virus infection. J Clin Pathol 43: 844–846PubMedCrossRefGoogle Scholar
  22. Rohatiner A, d’Amore F, Coiffier B et al. (1994) Report on a workshop convened to discuss on pathological and staging classifications of gastrointestinal tract lymphoma. Ann On-col 5: 397–400Google Scholar
  23. Schneider U, Ruhnke M, Delecluse HJ, Huhn D (1997) Treatment of EBV-associated lymphoproliferative disorders in HIV-infected patients with foscarnet. J Acquir Immune Defic Syndr Hum Retrovirol 14, abstract 97Google Scholar
  24. Smith C, Lilly S, Mann KP et al. (1998) AIDS-related malignancies. Ann Med 30: 323–344PubMedCrossRefGoogle Scholar
  25. Tirelli U, Errante D, Dolcetti R et al. (1995) Hodgkin’s disease and human immunodeficiency virus infection: Clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and tumors. J Clin Oncol 13: 1758–1767PubMedGoogle Scholar
  26. Weiß R, Huhn D, Mitrou P et al. (1998) HIV-related non-Hodgkin’s lymphoma: CHOP induction therapy and interferona-2b/Zidovudine maintenance therapy. Leuk Lymphoma 29: 103–118PubMedCrossRefGoogle Scholar
  27. Yee J, Wall SD (1995) Gastrointestinal manifestations of AIDS. Gastrointestinal Clin North Am 24: 413–434Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • D. Huhn

There are no affiliations available

Personalised recommendations